Navigation Links
SomaLogic and Otsuka Enter Into Research Collaboration
Date:5/9/2008

esearches, develops, manufactures and markets innovative and original products, with a focus on pharmaceutical products for the treatment of diseases and consumer products for the maintenance of everyday health. Otsuka is committed to being a corporation that creates global value, adhering to the high ethical standards required of a company involved in human health and life, maintaining a dynamic corporate culture, and working in harmony with local communities and the natural environment. The Otsuka Pharmaceutical Group comprises 99 companies and employs approximately 31,000 people in 18 countries and regions worldwide. Otsuka and its consolidated subsidiaries earned US $7.2 billion in annual revenues in fiscal 2006.


'/>"/>
SOURCE SomaLogic, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
2. Otsuka Pharmaceutical and PDL BioPharma Close Sale of IV Busulfex
3. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
4. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
5. Baxa Announces 2008 Dates for STAR Center Professional Pharmacy and Cleanroom Training
6. Center for Molecular Medicine Only Regional Provider of Test Suggested in FDA Alert on Prescribing Codeine to Nursing Mothers
7. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
8. UniCare Unveils Community Resource Center in Topeka to Serve Medicaid Enrollees
9. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
10. Neogen Acquires Kane Enterprises
11. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Jan. 22, 2015   Cypher Genomics, Inc., ... (NASDAQ: SQNM ), the leading molecular ... next generation noninvasive prenatal tests (NIPT). Through this ... called Mantis™, to advance analysis of clinically-relevant fetal ...
(Date:12/24/2014)... , Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... (NYSE: MDT ) has submitted a pre-market ... (FDA) for the use of Medtronic,s SynchroMed ® ... catheter) for use with United Therapeutics, Remodulin ® ...
(Date:12/24/2014)... (PRWEB) December 23, 2014 GMO corn cases ... Syngenta, are in the process of being consolidated in a ... In Re: Syngenta AG MIR 162 Corn Litigation, MDL No. ... Kansas. , Management of the Syngenta GMO corn multidistrict litigation ...
(Date:12/24/2014)... Dallas, Texas (PRWEB) December 23, 2014 ... mercaptan such as its definition, classification, application and ... manufacturing process, and product cost structure. Production is ... also covers upstream raw materials, equipment, downstream client ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2
... ANGELES, Nov. 17, 2011 Webcor Builders, an award-winning ... types, announced today it has been selected by the ... (LA BioMed) as the general contractor of the initial ... which will be located within the 72-acre Harbor-UCLA Medical ...
... Antelope Valley Hospital ... MASI ) today jointly announce the hospital,s ... advanced noninvasive patient monitoring capabilities that offer immediate, ... conversion equips Antelope Valley,s only full-service hospital with ...
... SeraCare Life Sciences, Inc. (NASDAQ: SRLS ), ... services to facilitate the discovery, development and production of ... its 2011 fiscal fourth quarter and year ended September ... the fourth quarter, we drove an improvement in the ...
Cached Biology Technology:Webcor Builders Selected as the General Contractor for First Phase of LA BioMed's New Campus Master Plan 2Webcor Builders Selected as the General Contractor for First Phase of LA BioMed's New Campus Master Plan 3Antelope Valley Hospital Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 2Antelope Valley Hospital Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 3Antelope Valley Hospital Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 4Antelope Valley Hospital Converts to Masimo rainbow SET for State-of-the-Art Noninvasive Patient Monitoring Capabilities 5SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results 2SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results 3SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results 4SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results 5SeraCare Reports Fiscal Year 2011 and Fourth Quarter Financial Results 6
(Date:12/19/2014)... VEGAS , Dec. 18, 2014   LaunchKey , ... for the post-password and Internet of Things era, today ... funding. The venture round was led by Metamorphic Ventures ... Rimrock Venture Partners, VegasTechFund, and others.  LaunchKey has raised ...
(Date:12/17/2014)... , Dec. 15, 2014  HITLAB SM announced ... audit to confirm its adherence to current U.S. Food ... to conduct regulated smart device and smart phone application ... research quality. "HITLAB is determined to improve ...
(Date:12/17/2014)...  Automation is fundamentally transforming the travel experience and nowhere ... the past decade, ePassports, biometric readers, and secure document ... border control via eGates and Automated Passport Control (APC) ... land borders across the globe. According ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... In a finding that could save thousands of lives a ... that a blood vessel disorder leading to unpredictable, sometimes fatal, ... the same statin drugs that millions of people take to ... in mice are confirmed in a pilot trial with people, ...
... French . , Montreal, January 26, 2009 ... researchers on downstream and upstream water from the ... of chemotherapy products and certain hypertension and cholesterol ... medication), methotrexate and cyclophosphamide (two products used in ...
... A new study by researchers at NYU Langone ... genetic testing among consumers for life altering and ... cancer, heart disease, dwarfism and shortened lifespan from ... are less interested in prenatal genetic testing for ...
Cached Biology News:Statins may treat blood vessel disorder that can lead to fatal strokes 2Statins may treat blood vessel disorder that can lead to fatal strokes 3Hypertension and cholesterol medications present in water released into the St. Lawrence River 2Consumers desire more genetic testing, but not designer babies 2Consumers desire more genetic testing, but not designer babies 3